IDENTIFICATION OF RISK FACTORS FOR THE DEVELOPMENT OF NEPHRITIS IN PEDIATRIC HEMORRHAGIC VASCULITIS
Keywords:
hemorrhagic vasculitis, Immunoglobulin A vasculitis, secondary nephritis, pediatric nephrology, risk factors, chronic kidney disease, purpura, renal monitoring.Abstract
Hemorrhagic vasculitis, internationally recognized as Immunoglobulin A vasculitis, is the most prevalent systemic vasculitis in the pediatric population. While the disease is generally self-limiting, the long-term prognosis is almost exclusively dictated by the occurrence and severity of renal involvement, termed secondary nephritis. This comprehensive observational study aims to meticulously identify and quantify the clinical and laboratory risk factors associated with the development of nephritis in a specifically defined cohort of forty-eight pediatric patients. The clinical investigation was conducted at the Andijan Regional Children's Multidisciplinary Medical Center. Through rigorous statistical analysis of presenting symptoms, disease duration, and laboratory biomarkers, the study delineates specific predictive phenotypes. The findings demonstrate that older age at onset, the persistence of the purpuric rash beyond one month, severe gastrointestinal manifestations, and elevated baseline systemic inflammatory markers are profound, independent predictors for subsequent renal compromise. The research emphasizes the critical necessity for prolonged, targeted nephrological monitoring in high-risk pediatric subsets to prevent irreversible chronic kidney disease.
References
1.Ozen, S., Pistorio, A., Iusan, S. M., et al. (2010). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Annals of the Rheumatic Diseases, 69(5), 798-806.
2.Trnka, P. (2013). Henoch-Schönlein purpura in children. Journal of Paediatrics and Child Health, 49(12), 995-1003.
3.Davin, J. C., & Coppo, R. (2014). Henoch-Schönlein purpura nephritis in children. Nature Reviews Nephrology, 10(10), 563-573.
4.McCarthy, H. J., & Tizard, E. J. (2010). Clinical practice: Diagnosis and management of Henoch-Schönlein purpura. European Journal of Pediatrics, 169(6), 643-650.
5.Jauhola, O., Ronkainen, J., Koskimies, O., et al. (2010). Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study. Pediatrics, 126(6), 1168-1174.
6.Sano, H., Izumida, M., Mutoh, Y., et al. (2002). Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura. European Journal of Pediatrics, 161(4), 196-201.
7.Rigante, D., Castellazzi, L., Bosco, A., et al. (2013). Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura? Autoimmunity Reviews, 12(10), 1016-1021.
8.Shin, J. I., Park, J. M., Shin, Y. H., et al. (2006). Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schönlein purpura. Scandinavian Journal of Rheumatology, 35(1), 56-60.
9.Kaku, Y., Nohara, K., Honda, S. (1998). Renal involvement in Henoch-Schönlein purpura: A multivariate analysis of risk factors. Kidney International, 53(6), 1755-1759.
10.Coppo, R., Mazzucco, G., Cagnoli, L., et al. (2006). The significance of mucosal immunity in the pathogenesis of IgA nephropathy and Henoch-Schönlein purpura nephritis. Pediatric Nephrology, 21(11), 1636-1644.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal